Tuesday, June 09, 2020 7:32:35 AM
A staging website for Markman Biologics was brought active last night. Provides more information on the people involved and clinical testing plans. Still no confirmation/indication on this site that Markman Biologics is the RM target for AERS.
From an overall fundamental/structural perspective, AERS is a relatively unattractive shell. But in the current market environment, much worse looking shells/situations are having some pretty significant moves.
https://markmanbiologicsstaging.com/
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM